Murayama N, Shimada M, Yamazoe Y, Kato R
Department of Pharmacology, School of Medicine, Keio University, Tokyo, Japan.
Mol Pharmacol. 1991 Jun;39(6):811-7.
Suppression of two major phenobarbital-inducible cytochrome P-450s, P450IIB1 and P450IIB2, by thyroid hormone was studied and compared with growth hormone (GH)-induced suppression in rats in vivo and hepatocytes in primary culture in vitro. Treatment of adult male rats with 50 micrograms/kg triiodothyronine (T3) reduced the constitutively expressed amounts of P450IIB1 (up to 1 pmol/mg of protein) and P450IIB2 (2-5 pmol/mg of protein) to 42% and 3% of their levels in nontreated controls. Thyroidectomy increased the hepatic contents of P450IIB2 (to levels of 50-80 pmol/mg of protein) and, to a lesser extent, P450IIB1 (1-5 pmol/mg of protein) in male and female rats. Supplement of T3 to thyroidectomized rats reversed the increased contents to levels similar to those observed in normal rats. Hypophysectomy also increased both P450IIB1 and P450IIB2 protein, and their levels in both sexes were similar to that of P450IIB2 in thyroidectomized rats. Treatment of hypophysectomized rats with T3 as well as human GH suppressed hepatic contents of P450IIB1 and P450IIB2. In a hepatocyte culture including 2 mM phenobarbital, T3 and GH suppressed both P450IIB1 and P450IIB2. Other thyroid hormone derivatives, including thyroxine, D-T3, and reversed T3, also showed suppressive effects, in parallel with the potencies for their stimulatory action that have been reported. These results indicate that thyroid hormone may suppress both P450IIB1 and P450IIB2 by a direct effect on the liver, but not by an indirect effect through the modulation of pituitary GH synthesis. The high susceptibility of hepatic P450IIB2 to thyroid hormone-induced suppression also indicates that constitutive and phenobarbital-induced levels of P450IIB2 are suppressively regulated preferentially by thyroid hormone, in contrast to the high susceptibility to GH of P450IIB1 in rat liver. In addition, a difference in the suppressive mechanisms of thyroid hormone and GH was suggested by the difference in susceptibility to cycloheximide.
研究了甲状腺激素对两种主要的苯巴比妥诱导型细胞色素P-450,即P450IIB1和P450IIB2的抑制作用,并与生长激素(GH)在体内对大鼠以及在体外原代培养的肝细胞中诱导的抑制作用进行了比较。用50微克/千克三碘甲状腺原氨酸(T3)处理成年雄性大鼠,可使组成性表达的P450IIB1(最高达1皮摩尔/毫克蛋白质)和P450IIB2(2 - 5皮摩尔/毫克蛋白质)的量降至未处理对照水平的42%和3%。甲状腺切除术增加了雄性和雌性大鼠肝脏中P450IIB2的含量(达到50 - 80皮摩尔/毫克蛋白质的水平),对P450IIB1的增加程度较小(1 - 5皮摩尔/毫克蛋白质)。给甲状腺切除的大鼠补充T3可使增加的含量恢复到与正常大鼠相似的水平。垂体切除术也增加了P450IIB1和P450IIB2的蛋白质含量,且两性中的水平与甲状腺切除大鼠中P450IIB2的水平相似。用T3以及人GH处理垂体切除的大鼠可抑制肝脏中P450IIB1和P450IIB2的含量。在含有2毫摩尔苯巴比妥的肝细胞培养物中,T3和GH均抑制P450IIB1和P450IIB2。其他甲状腺激素衍生物,包括甲状腺素、D-T3和反式T3,也显示出抑制作用,与其已报道的刺激作用强度平行。这些结果表明,甲状腺激素可能通过对肝脏的直接作用而非通过调节垂体GH合成的间接作用来抑制P450IIB1和P450IIB2。肝脏P450IIB2对甲状腺激素诱导的抑制高度敏感,这也表明与大鼠肝脏中P450IIB1对GH的高度敏感性相反,P450IIB2的组成性和苯巴比妥诱导水平优先受到甲状腺激素的抑制调节。此外,甲状腺激素和GH抑制机制的差异通过对放线菌酮敏感性的差异得以体现。